Capital Region Southwest Campus — Jefferson City, Missouri

Capital Region Southwest Campus is a clinical research site located in Jefferson City, Missouri, United States 65109.

Crixeo Health Trust Score: 86/100 (GOOD). This profile has not yet been claimed by the site owner.

Capital Region Southwest Campus has participated in 87 clinical trials with 35 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 86/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Capital Region Southwest Campus?

Capital Region Southwest Campus has a Crixeo Trust Score of 86/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Capital Region Southwest Campus conducted?

Capital Region Southwest Campus has 87 clinical trials on record, with 35 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is Capital Region Southwest Campus accredited by Crixeo Health?

Capital Region Southwest Campus has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Capital Region Southwest Campus?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.